Empirical therapy and teicoplanin use in periprosthetic joint infecti

Murat BOZKURT; Gülruhsar YILMAZ; Zeliha KOÇAK TUFAN; Hatice Rahmet GÜNER1; Aybegüm ÖZŞAHİN; Mehmet Akın TAŞYARAN

Journals / Turkish Journal of Medical Sciences / 2017 / Cilt: 47 - Sayı: 6

Empirical therapy and teicoplanin use in periprosthetic joint infecti

Journal: Turkish Journal of Medical Sciences
Issue: 2017 · Cilt: 47 - Sayı: 6
Pages: 1947–1749
Publication Date: 2022-11-05
DOI: —

🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.

DergiPark Record ↗

🔖

Cite This Article

BOZKURT, M., YILMAZ, G., TUFAN, Z. K., GÜNER1, H. R., ÖZŞAHİN, A., TAŞYARAN, M. A. (2022). Empirical therapy and teicoplanin use in periprosthetic joint infecti. Turkish Journal of Medical Sciences, Cilt: 47 - Sayı: 6, 1947–1749. https://ajindex.com/articles/610505

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (4)

Belmont PJ, Goodman GP, Rodriguez M, Bader JO, Waterman BR, Schoenfeld AJ. Predictors of hospital readmission following revision total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2016; 24: 3329-3338
Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR; Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56: e1-e25
Barrett L, Atkins B. The clinical presentation of prosthetic joint infection. J Antimicrob Chemother 2014; 69: i25-i27
Tornero E, García-Ramiro S, Martínez-Pastor JC, Bori G, Bosch J, Morata L, Sala M, Basora M, Mensa J, Soriano A. Prophylaxis with teicoplanin and cefuroxime reduces the rate of prosthetic joint infection after primary arthroplasty. Antimicrob Agents Chemother 2015; 59: 831-837.